Should the patients with advanced primary liver cancer get benefit from camrelizumab and lenvatinib combination treatment?

Huang Ying, Yang Zhiyong, Luo Ming

Journal of Practical Hepatology . 2024, (4): 595 -598 . DOI: 10.3969/j.issn.1672-5069.2024.04.026